• Call(WhatsApp Us)

    +8615360806100
  • Email Us

    cherry@laeyo.com
  • 广州市花都区花山镇华辉路18号

    微观化妆品创意产业园E栋整栋

Who Controls a Custom Face Cream Formula When a Saudi Brand Uses an Overseas OEM Laboratory?

A Saudi brand commissioning a custom face cream from an overseas OEM laboratory usually assumes one question — “who owns the formula?” — has one answer. In practice, three parties hold three different kinds…

Category: Skincare Sourcing Guides • Author: laeyo • Published: 2026-11-11 • Views: 44

A Saudi brand commissioning a custom face cream from an overseas OEM laboratory usually assumes one question — “who owns the formula?” — has one answer. In practice, three parties hold three different kinds of control, and the gaps between them are exactly where launches stall. The brand controls the market, the price architecture and the claims. The overseas lab controls the formula as a manufacturing instruction, together with the batch records and release criteria. The Saudi importer or notifier carries the legal responsibility for placing the product on the market, including SFDA cosmetic notification under the GSO safety and claims framework. This guide maps those boundaries and lists the documents to request so that control is defined in writing before the first pilot batch — not discovered after the first shipment.

Short answer: three parties, three different kinds of control

  • The Saudi brand controls the commercial brief, target retail price, channel strategy, label content and marketing claims — but only up to the limit of the evidence that exists for the finished product.
  • The overseas OEM laboratory controls the formula as a production instruction: quantitative formula, process parameters, specifications, batch records and QC release. It is responsible for the truth and completeness of the formula, INCI, COA, specifications, process, quality, and the safety and efficacy technical data behind them.
  • The Saudi importer / notifier holds the legal responsibility on the local market: cosmetic notification through the SFDA electronic system, import permits, maintenance of the product information file, and final Arabic/English label approval.
  • No one controls it by default. Ownership, exclusivity, data-transfer rights and second-source options exist only if the contract says so. A verbal promise of “permanent exclusivity” is not a control mechanism, and it will not survive a change of account manager.

Decision-rights map: who decides what on a custom face cream

Decision area Saudi brand Overseas OEM lab Importer / notifier
Target market and positioning Decides Advises on what is technically feasible Confirms the entry route and local requirements
Formula composition and process Approves the brief and the golden sample Owns and controls Receives a summary for the dossier
Exclusivity (who else receives the base) Negotiates scope and term Grants only within the signed contract scope Not involved
Technical dossier: INCI, COA, SDS, specs, stability, micro Receives a complete copy Authors and signs Holds it for notification and inspection
Label artwork and language Approves brand content Supplies technical input (INCI, net content, usage) Approves the final Arabic/English text
Claims and advertising Decides, within evidence Verifies technical accuracy of wording Checks market compliance
Notification and import permit Funds and supports Provides supporting documents Files and holds the record
Change control (reformulation, supplier swap) Approves before implementation Notifies and re-validates Updates the dossier if the change is material

What “formula control” actually means — four separate layers

1. The formula as a commercial asset

Most OEM laboratories bring background intellectual property: existing emulsion platforms, established preservation systems, supplier-approved raw material combinations. Your custom work is usually built on top of that base. The contract should separate background IP from project-specific development, name the formula by its internal code, and state what happens to the documentation if the relationship ends. Without that clause, “we developed it together” is the only thing either side can prove.

2. The formula as a manufacturing instruction

Even when a brand owns the recipe text, it does not automatically own the ability to make it. A face cream depends on phase temperatures, homogenization speed and time, cooling ramp, pH adjustment point, preservative addition temperature, fill temperature and a viscosity window. Ask for the scope of the technical transfer package in writing, and expect that a second manufacturing site will still need engineering batches to match texture and stability.

3. The formula as a regulatory object

For Saudi entry, the notifier needs a coherent, consistent dossier. Two failures recur: the INCI printed on the label does not match the INCI implied by the quantitative formula, and the stability or microbiology data was generated on a laboratory batch rather than a production-representative batch. Both are avoidable if the documentation is treated as one package from the start rather than assembled at the end.

4. The formula as a market claim

Claims belong to the brand, but they are constrained by the evidence the factory and the labs can support. Under the SFDA and GSO framework, a cosmetic may not carry drug or therapeutic claims. Aromatherapy-style wording — sleep support, anxiety relief, treatment of a skin condition — can change how the product is classified and create a compliance problem that no amount of good packaging will fix.

Minimum document pack to request before you sign

Document or test What it proves Issued by
Quantitative formula, referenced by code What is actually being manufactured OEM laboratory
INCI declaration plus fragrance allergen calculation That the label matches the formula at use concentration OEM laboratory
Finished-product specification sheet Release criteria: appearance, pH, viscosity, odor, identity checks OEM laboratory
Batch COA and retention sample policy Batch-level conformity and traceability OEM quality control
SDS in GHS format Handling, storage and transport requirements OEM laboratory
Stability data: accelerated, real-time, and high-temperature cycling Shelf life claim and resistance to Saudi summer and shipment conditions OEM laboratory or third-party lab
Preservative efficacy (challenge test) and microbiological testing That the preservation system holds under real use Third-party laboratory
Packaging compatibility report That jar, airless pack or pump, liner and label survive the product OEM plus packaging supplier
GMP evidence: ISO 22716 / GMPC certificate with facility scope Process and hygiene control at the actual production site OEM laboratory
Artwork file with Arabic/English text Market-ready label compliant with SFDA/GSO requirements Brand plus notifier

Request list you can forward to a supplier today

  • Provide the quantitative formula reference code and confirm who owns each component of the IP.
  • Confirm, in writing, whether exclusivity applies and specify market, channel, term and minimum volume.
  • Attach the stability protocol, including high-temperature and shipment-simulation conditions.
  • Provide the challenge test report and the microbiological specification for release.
  • Share the packaging compatibility report covering viscosity, leak, liner compatibility and label adhesion.
  • Attach the batch record template and confirm retention sample duration.
  • Confirm the change-notification window before any raw material supplier substitution.
  • Provide the technical transfer scope if a second manufacturing site is ever required.
  • Confirm which documents will be issued to our Saudi notifier and in what format.
  • Confirm the claims you can technically support, and the ones you cannot.

Contract clauses that decide control

  • Definition of “Formula.” State whether it means qualitative composition, quantitative composition, or quantitative composition plus process parameters. These are three very different levels of control.
  • IP schedule. List background IP, project-specific development and improvements made during scale-up, and assign each one.
  • Exclusivity scope. Specify market, channel, term, volume commitment and whether the restriction covers the base, the fragrance or the full formula. Undefined exclusivity is the most common source of disputes in private-label skincare.
  • Data transfer obligation. Name the deliverables and the format: INCI, specification sheet, COA, SDS, stability summary, allergen calculation.
  • Change control. Require notification before any change affecting texture, pH, viscosity, preservative system or fragrance, plus re-testing obligations.
  • Continuity and second source. Define what happens if a raw material is discontinued or the manufacturing site changes.
  • Claims approval workflow. State who signs off label text and marketing copy, and require written technical review before publication.

Red lines: what not to cut

  • Do not skip high-temperature stability and shipment simulation to save four weeks; a separated emulsion in a Jeddah warehouse costs far more.
  • Do not release without a challenge test on the final preservation system at the final use concentration.
  • Do not approve packaging without a compatibility report, including label adhesion under heat and humidity.
  • Do not print a label before the INCI and fragrance allergen calculation are reconciled with the quantitative formula.
  • Do not ship before the Saudi notifier has filed the cosmetic notification and the Arabic/English label is approved.
  • Do not let marketing publish therapeutic or aromatherapy claims that the dossier cannot support.
  • Do not accept a COA that cannot be traced to a specific batch number and retention sample.

Common failure modes and how to prevent them

1. The base appears in a competitor’s line six months later

  • Symptom: A near-identical texture and scent launches under another brand.
  • Root cause: Exclusivity was agreed verbally or limited to the fragrance, not the emulsion base.
  • Prevention: Define exclusivity by formula code, market, channel and term, with a volume commitment.
  • What to request: A signed exclusivity schedule naming the formula code and the scope of restriction.

2. The cream separates or the pump fails after two weeks in market

  • Symptom: Phase separation, syneresis, discoloration, leaking airless packs, or labels lifting at the edges.
  • Root cause: Packaging compatibility was assessed on appearance only — no viscosity match to the pump, no liner compatibility check, no heat and humidity adhesion test.
  • Prevention: Run a compatibility study on the actual pack with the actual bulk, including a heat-and-humidity storage period and a transit simulation.
  • What to request: Packaging compatibility report from the OEM plus the packaging supplier’s material and liner specification.

3. The dossier does not match the product

  • Symptom: The notifier cannot reconcile the label INCI with the formula, or a COA is missing for a shipped batch.
  • Root cause: Documentation was assembled after production, from different document versions.
  • Prevention: Treat the technical file as a single controlled package, versioned at the golden sample stage.
  • What to request: A documentation index with version numbers, plus a batch-specific COA and retention sample reference.

4. A raw material is swapped without notice

  • Symptom: Viscosity drifts, texture feels different, or the INCI on the printed carton is no longer accurate.
  • Root cause: No change-control clause, or a substitution made to protect a delivery date.
  • Prevention: Require written notification and re-testing before any material or supplier change.
  • What to request: Change-control procedure plus a sample of the re-validated bulk for approval.

5. Marketing copy crosses into drug claims

  • Symptom: Copy referencing treatment of eczema or acne, or aromatherapy claims such as sleep support, appears on the product page.
  • Root cause: Copy was written by marketing without technical review, and no one checked it against the classification rules.
  • Prevention: Route all claims through a documented technical review before publication.
  • What to request: The factory’s written technical review of each claim, and a list of claims it will not support.

6. Cargo is held because no local notifier was appointed

  • Symptom: Goods arrive without an import permit or without a completed cosmetic notification.
  • Root cause: The factory was expected to handle local notification, which it cannot legally do.
  • Prevention: Appoint the Saudi importer or notifier before the pilot run, and confirm the document handover list.
  • What to request: A signed handover list of documents the factory will issue and the notifier will file.

Stage gates that keep control visible

Gate Output Sign-off
G0 Requirement intake Project brief with market, price band and channel Brand
G1 Project set-up Risk list including regulatory and packaging risks Brand and OEM
G2 Sample review Candidate textures and structured feedback form Brand
G3 Engineering verification Test records, stability and compatibility data OEM quality
G4 Pilot confirmation Pilot report and approved golden sample Brand and OEM
G5 Bulk release Release records and retention samples OEM quality control
G6 Repurchase review Improvement list and repeat-order plan Both parties

Stability, microbiology and packaging compatibility run in parallel with artwork development. Notification can only be filed once the formula and the final label are frozen, so those two freeze dates — not the production date — usually determine the launch date.

FAQ

If we pay for the development, do we own the formula?

Not automatically. Ownership depends on how the contract separates background IP — the OEM’s existing platforms — from project-specific development. Ask for a written IP schedule that names the formula by code and states what transfers to you and what remains with the laboratory.

Can we move the formula to a second factory later?

Only if the contract grants data-transfer rights and the OEM provides a defined transfer package. Even then, expect engineering batches: process parameters such as homogenization speed, cooling ramp and fill temperature determine texture and stability as much as the ingredient list does.

Who is legally responsible for the product in Saudi Arabia?

The local importer or notifier carries the legal responsibility for the product on the Saudi market, including notification through the SFDA system and maintaining the product information file. The overseas factory is responsible for the truth and completeness of the technical data it supplies. A completed notification is a regulatory step, not an endorsement of the product.

Can we describe the cream as repairing the skin barrier or calming stress?

Barrier-support wording may be acceptable if you hold supporting evidence and it stays within cosmetic framing. Therapeutic and aromatherapy claims — treating a skin condition, improving sleep, relieving anxiety — can reclassify the product and should be avoided unless your regulatory adviser confirms otherwise.

How long does a custom face cream project take?

It depends on how much of the formula is genuinely custom. The long poles are usually stability and microbiology testing, packaging compatibility, and label approval with the notifier. Brands that freeze the formula and artwork early typically compress the schedule far more than brands that re-open the brief during pilot.

Next step

Send the brief with the target market, SKU count and formats, positioning, packaging direction and target launch date, and you will get a faster, more accurate quotation with the matching documentation list. Request a Quote

This article is informational only and is not legal advice. SFDA and GSO requirements, contract terms and label content should be confirmed with your regulatory consultant and legal counsel.

Hi, I'm your LAEYO representative, hope you like this blog post.

With more than 20 years of experience in OEM/ODM/Private Label Cosmetics, I'd love to share valuable knowledge related to cosmetics & skincare products from a top-tier Chinese supplier's perspective.

  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).